THE PRIMER
SCIENCE MADE SIMPLE
Stay Updated! Subscribe to The Primer
Share
Silencing Disease: Unveiling the Potential of ASO’s
Antisense oligonucleotide (ASO) technology revolutionizes disease treatment by specifically targeting and modifying RNA. This therapeutic class is rapidly gaining traction due to its precision in targeting proteins that are inaccessible to traditional treatments.
Special Delivery: Gene Therapy Vectors
There are two broad approaches to gene therapy treatment, in vivo and ex vivo, and each relies on a different gene vector to get the job done. Let’s take a closer look.
Branches of Biotechnology
Biotechnology uses living organisms or their components to address many of our largest global challenges in healthcare, agriculture, the environment, and industry.
Biotech vs. Biopharma: Understanding the Differences
Biotechnology, pharmaceuticals, and biopharmaceuticals: these terms and abbreviations (biotech, pharma, and biopharma, respectively) are everywhere in today’s lexicon. However, which aspect of research does each term refer to, and more importantly, how are they different?
Pathways to Progress: FDA Fast Tracks Huntington’s Treatments
The biotech sector is witnessing significant developments in the battle against Huntington’s Disease (HD).
AI Boosts Biologic Breakthroughs
The biopharmaceutical landscape is rapidly expanding at a CAGR of 12.5%, with its market value set to rise from USD 333.09 billion in 2022 to USD 856.1 billion by 2030.
Targeted Disruption: The Rise of PARP Inhibitors
The market for PARP inhibitors, a cornerstone in targeted cancer treatment, is projected to more than triple from $3 billion in 2022 to an estimated $10.3 billion by 2031.
The Evolution of SMA Care
Despite the limited treatment options available, recent biological and technological advancements have sparked new hope, opening up novel opportunities for treatment and care.
Liquid Biopsies Redefine Cancer Care
The in vitro diagnostics (IVD) market, already valued at USD $102 billion in 2024, is on the brink of transformation, driven by the surge in liquid biopsy technologies.
RNA Therapeutics: A Focus on Antisense
Unlock the potential of antisense technology. Discover how RNA therapeutics can target previously ‘undruggable’ molecules for effective manipulation.
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.